JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB144258

Fumitremorgin C (Tryptoquivaline), Chemosensitizing agent

Be the first to review this product! Submit a review

|

(1 Publication)

MW 379.5 Da, Purity >98%. Chemosensitizing agent. Potent and selective BCRP inhibitor. Selective AKT inhibitor. Selectively reverses resistance to and potentiates mitoxantrone (ab145668), doxorubicin (ab120629) and topotecan (ab120388) in BCRP-transfected cells. Mycotoxin. Shows antiproliferative effects. Shows tremorgenic effects in vivo. .

View Alternative Names

ABC transporter, ABC15, ABCG2_HUMAN, ABCP, ATP binding cassette sub family G (WHITE) member 2, ATP binding cassette transporter G2, ATP-binding cassette sub-family G member 2, BCRP, BCRP 1, BMDP, Breast cancer resistance protein, CD338, CDw338, CDw338 antigen, EST157481, GOUT1, MGC102821, MRX, MXR, MXR1, Mitoxantrone resistance-associated protein, Multi drug resistance efflux transport ATP binding cassette sub family G (WHITE) member 2, Placenta specific MDR protein, Placenta-specific ATP-binding cassette transporter, UAQTL1

1 Images
Chemical Structure - Fumitremorgin C (Tryptoquivaline), Chemosensitizing agent (AB144258)
  • Chemical Structure

Lab

Chemical Structure - Fumitremorgin C (Tryptoquivaline), Chemosensitizing agent (AB144258)

2D chemical structure image of ab144258, Fumitremorgin C (Tryptoquivaline), Chemosensitizing agent

Key facts

CAS number

118974-02-0

Purity

>98%

Form

Solid

form

Source

Aspergillus fumigatus

Molecular weight

379.5 Da

Molecular formula

C<sub>2</sub><sub>2</sub>H<sub>2</sub><sub>5</sub>N<sub>3</sub>O<sub>3</sub>

PubChem

403923

Nature

Native

Solubility

Soluble in DMSO to 10 mM

Biochemical name

Fumitremorgin C

Biological description

Chemosensitizing agent. Potent and selective BCRP inhibitor. Selective AKT inhibitor. Selectively reverses resistance to and potentiates mitoxantrone (ab145668), doxorubicin (ab120629) and topotecan (ab120388) in BCRP-transfected cells. Mycotoxin. Shows antiproliferative effects. Shows tremorgenic effects in vivo.

Canonical smiles

CC(=CC1C2=C(CC3N1C(=O)C4CCCN4C3=O)C5=C(N2)C=C(C=C5)OC)C

Isomeric smiles

CC(=C[C@H]1C2=C(C[C@@H]3N1C(=O)[C@@H]4CCCN4C3=O)C5=C(N2)C=C(C=C5)OC)C

InChi

InChI=1S/C22H25N3O3/c1-12(2)9-18-20-15(14-7-6-13(28-3)10-16(14)23-20)11-19-21(26)24-8-4-5-17(24)22(27)25(18)19/h6-7,9-10,17-19,23H,4-5,8,11H2,1-3H3/t17-,18-,19-/m0/s1

InChiKey

DBEYVIGIPJSTOR-FHWLQOOXSA-N

IUPAC Name

(1S,12S,15S)-7-methoxy-12-(2-methylprop-1-enyl)-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-14,20-dione

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 9:5695 PubMed30952903

2019

High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Šárka Šimečková,Zuzana Kahounová,Radek Fedr,Ján Remšík,Eva Slabáková,Tereza Suchánková,Jiřina Procházková,Jan Bouchal,Gvantsa Kharaishvili,Milan Král,Petr Beneš,Karel Souček
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com